XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Collaboration, License, and Other Agreements - North America - General Information (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2023
USD ($)
item
Mar. 31, 2022
USD ($)
Collaboration, License, Promotion and Other Commercial Agreements    
Research and development expense $ 12,847 $ 10,822
AbbVie Plc    
Collaboration, License, Promotion and Other Commercial Agreements    
Remaining commercial-period performance obligations | item 3  
Cost sharing amount, reduction to research and development $ 3,000 2,400
Collaborative arrangement, percentage of obligation of development costs incurred 50.00%  
Percentage of net profit from commercialization (as a percent) 50.00%  
Percentage of net loss from commercialization (as a percent) 50.00%  
North America | AbbVie Plc    
Collaboration, License, Promotion and Other Commercial Agreements    
Research and development expense $ 1,300 $ 1,700